In-licensing: Central Nervous System/Neurological/Epilepsy & Phase I/II

Latest: Watch here for details of new products and services.

Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Comparison
Forums: Visit our forums
Jobs: Visit our job site
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire New!
Contact us: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..4 of 4 - per page
Order by

Seeking licensing opportunities for the UK hospital market More

Acquisition of established pharmaceuticals in the UK market More

We are looking for products to treat CNS disorders More

Azur is interested in late stage or marketed products for the US market More

Displaying 1..4 of 4 - per page
Order by

Therapeutic target: Central Nervous System del; Neurological del; Epilepsy del
Development phase: Phase I/II del

Industry sector: Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Pharmaceutical; Research tools

Industry news: Pharmalicensing provides comprehensive industry coverage.